ArticleMikrochimica acta2018
Polystyrenesulfonate-coated nanoparticles with low cytotoxicity for determination of copper(II) via the luminescence of Tb(III) complexes with new calix[4]arene derivatives.
Article in Mikrochimica acta, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- The Synergy of Macrocycles and Heterocycles: A Review of Coordination Behavior, Sensing, and Functional Materials Based on Calixarenes.Molecules (Basel, Switzerland) · 2026Review
- Kinetics and Retention of Polystyrenesulfonate for Proteoglycan Replacement in Cartilage.Biomacromolecules · 2024Article
- Phosphineoxide-Chelated Europium(III) Nanoparticles for Ceftriaxone Detection.Nanomaterials (Basel, Switzerland) · 2023Article
- 1,3-Diketone Calix[4]arene Derivatives-A New Type of Versatile Ligands for Metal Complexes and Nanoparticles.Molecules (Basel, Switzerland) · 2021Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The authors describe new ligands with two 1,3-diketone groups and two heteroaromatic (pyridyl or quinolyl) moieties embedded to the upper and lower rims of dibromo-substituted calix[4]arene scaffold. The ligands bind Tb(III) ions in alkaline DMF solutions to form 1:1 complexes. The strong Tb(III)-centered luminescence (with excitation/emission peaks at 330/545 nm) of the complexes results from efficient ligand-to-metal energy transfer. The complexes were incorporated into polystyrenesulfonate (PSS) colloids by diluting a DMF solution of the complex with aqueous solution of PSS. The luminescence of the colloids is quenched by copper(II), and this was used to develop a method for its fluorometric determination in nanomolar concentrations. The lower limit of detection is 0.88 nM. Quenching is a result of (a) ion exchange which converts the terbium complexes into their copper counterparts, and (b) energy transfer from Tb(III) to Cu(II) complexes. The low cytotoxicity of the colloidal nanoprobe conceivably makes it a promising tool for use in cellular imaging. Graphical abstract New calix[4]arene derivative provide efficient binding sites for Tb(III) and Cu(II) ions. The Tb(III) complexes were embedded to core-shell nanoparticles by solvent-mediated aggregation followed by polystryrenesulfonate deposition. The nanoparticles exhibit luminescence response on copper ions in nanomolar concentration range.
Indexed as
Identifiers
30043251What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.